Validation of multi-gene biomarkers for clinical outcomes is one of the most important issues for cancer prognosis. An important source of information for virtual validation is the high number of available cancer datasets. Nevertheless, assessing the prognostic performance of a gene expression signature along datasets is a difficult task for Biologists and Physicians and also time-consuming for Statisticians and Bioinformaticians. Therefore, to facilitate performance comparisons and validations of survival biomarkers for cancer outcomes, we developed SurvExpress, a cancer-wide gene expression database with clinical outcomes and a web-based tool that provides survival analysis and risk assessment of cancer datasets. The main input of SurvExp...
Multiple clinical studies have correlated gene expression with survival outcome in cancer on a genom...
[Motivation]: Modern genomic technologies allow us to perform genome-wide analysis to find gene mark...
Background: Ovarian cancer has the lowest survival rate of all gynaecologic cancers and is character...
Validation of multi-gene biomarkers for clinical outcomes is one of the most important issues for ca...
Validation of multi-gene biomarkers for clinical outcomes is one of the most important issues for ca...
Validating prognostic or predictive candidate genes in appropriately powered breast cancer cohorts a...
Background Identification of prognostic mRNA biomarkers has been done for various cancer types. The...
Validating prognostic or predictive candidate genes in appropriately powered breast cancer cohorts a...
Abstract Background Censored data are increasingly common in many microarray studies that attempt to...
Ovarian cancer is one of the most aggressive and highly lethal gynecological cancers. The purpose of...
Survival analysis methods are often used in cancer studies. It has been shown that the combination o...
Predictive biomarkers for patient stratification play critical roles in realizing the paradigm of pr...
Over time, much has been done in attempt to understand the various causes and complex molecular mech...
Microarray-based gene expression analysis holds promise of improving prognostication and treatment d...
<p>Kaplan-Meier Plotter (A,C,E) and Gene Expression-Based Outcome for Breast Cancer Online (B,D,F) d...
Multiple clinical studies have correlated gene expression with survival outcome in cancer on a genom...
[Motivation]: Modern genomic technologies allow us to perform genome-wide analysis to find gene mark...
Background: Ovarian cancer has the lowest survival rate of all gynaecologic cancers and is character...
Validation of multi-gene biomarkers for clinical outcomes is one of the most important issues for ca...
Validation of multi-gene biomarkers for clinical outcomes is one of the most important issues for ca...
Validating prognostic or predictive candidate genes in appropriately powered breast cancer cohorts a...
Background Identification of prognostic mRNA biomarkers has been done for various cancer types. The...
Validating prognostic or predictive candidate genes in appropriately powered breast cancer cohorts a...
Abstract Background Censored data are increasingly common in many microarray studies that attempt to...
Ovarian cancer is one of the most aggressive and highly lethal gynecological cancers. The purpose of...
Survival analysis methods are often used in cancer studies. It has been shown that the combination o...
Predictive biomarkers for patient stratification play critical roles in realizing the paradigm of pr...
Over time, much has been done in attempt to understand the various causes and complex molecular mech...
Microarray-based gene expression analysis holds promise of improving prognostication and treatment d...
<p>Kaplan-Meier Plotter (A,C,E) and Gene Expression-Based Outcome for Breast Cancer Online (B,D,F) d...
Multiple clinical studies have correlated gene expression with survival outcome in cancer on a genom...
[Motivation]: Modern genomic technologies allow us to perform genome-wide analysis to find gene mark...
Background: Ovarian cancer has the lowest survival rate of all gynaecologic cancers and is character...